The combined measurement of GFAP and UCH-L1 provides complementary insights into glial and neuronal damage and forms the basis of the Banyan Brain Trauma IndicatorTM, the first FDA-approved in vitro diagnostic test for TBI. This evidence concerns the gene UCHL1 and brain injury.